Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News PRA Health Sciences Inc. PRAH

PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In... see more

Recent & Breaking News (NDAQ:PRAH)

PRA Health Sciences to Report Third Quarter 2020 Earnings

GlobeNewswire October 7, 2020

PRA Health Sciences selected by BARDA to be a member of its exclusive Clinical Studies Network

GlobeNewswire October 6, 2020

PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials

Thomson Reuters ONE September 18, 2020

PRA Health Sciences Announces Appointment of New Director

GlobeNewswire September 15, 2020

PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia

PR Newswire September 3, 2020

PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance

GlobeNewswire August 6, 2020

PRA Health Sciences to Report Second Quarter 2020 Earnings

GlobeNewswire July 2, 2020

PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology

GlobeNewswire June 18, 2020

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

Thomson Reuters ONE June 12, 2020

PRA Health Sciences, Inc. Reports First Quarter 2020 Results, Withdraws Full Year 2020 Guidance Due to Uncertain COVID-19 Impact and Provides Second Quarter 2020 Guidance

GlobeNewswire April 30, 2020

PRA Health Sciences to Report First Quarter 2020 Earnings

GlobeNewswire April 13, 2020

Symphony Health to provide free access to new MetysTM COVID-19 Module for U.S. based life sciences industry during pandemic

Thomson Reuters ONE April 8, 2020

PRA Health Sciences expands remote clinical study support with its Mobile Health Platform during COVID-19 pandemic

Thomson Reuters ONE March 24, 2020

PRA Health Sciences Launches COVID-19 Monitoring Program

GlobeNewswire March 20, 2020

Symphony Health Partners with Datavant for the Industry's Deepest View of the Patient Journey

GlobeNewswire March 11, 2020

PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2019 Results and Provides First Quarter and Full Year 2020 Guidance

GlobeNewswire February 20, 2020

PRA Health Sciences to Report Fourth Quarter 2019 Earnings

GlobeNewswire February 3, 2020

Perspecta and PRA Health Sciences complete successful modernization of Million Veteran Program for U.S. Department of Veterans Affairs

PR Newswire January 7, 2020

PRA Health Sciences, Inc. Reports Third Quarter 2019 Results and Updates Full Year 2019 Guidance

GlobeNewswire October 30, 2019

PRA Health Sciences to Report Third Quarter 2019 Earnings

GlobeNewswire October 9, 2019